Avalo Therapeutics Stock Forward View - Simple Regression
| AVTX Stock | USD 15.11 0.14 0.92% |
Avalo Stock outlook is based on your current time horizon.
At this time, the RSI of Avalo Therapeutics' share price is approaching 43. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Avalo Therapeutics, making its price go up or down. Momentum 43
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (1.45) | EPS Estimate Current Year (6.67) | EPS Estimate Next Year (4.55) | Wall Street Target Price 34.375 | EPS Estimate Current Quarter (1.61) |
Using Avalo Therapeutics hype-based prediction, you can estimate the value of Avalo Therapeutics from the perspective of Avalo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Avalo Therapeutics using Avalo Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Avalo using crowd psychology based on the activity and movement of Avalo Therapeutics' stock price.
Avalo Therapeutics Implied Volatility | 1.78 |
Avalo Therapeutics' implied volatility exposes the market's sentiment of Avalo Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Avalo Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Avalo Therapeutics stock will not fluctuate a lot when Avalo Therapeutics' options are near their expiration.
The Simple Regression forecasted value of Avalo Therapeutics on the next trading day is expected to be 16.63 with a mean absolute deviation of 1.26 and the sum of the absolute errors of 78.26. Avalo Therapeutics after-hype prediction price | USD 15.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Avalo Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Avalo contract
Based on the Rule 16, the options market is currently suggesting that Avalo Therapeutics will have an average daily up or down price movement of about 0.11% per day over the life of the 2026-04-17 option contract. With Avalo Therapeutics trading at USD 15.11, that is roughly USD 0.0168 . If you think that the market is fully incorporating Avalo Therapeutics' daily price movement you should consider acquiring Avalo Therapeutics options at the current volatility level of 1.78%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Avalo Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Avalo Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Avalo Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Avalo Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Avalo Therapeutics' open interest, investors have to compare it to Avalo Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Avalo Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Avalo. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Avalo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Avalo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Avalo using various technical indicators. When you analyze Avalo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Avalo Therapeutics Simple Regression Price Forecast For the 1st of February
Given 90 days horizon, the Simple Regression forecasted value of Avalo Therapeutics on the next trading day is expected to be 16.63 with a mean absolute deviation of 1.26, mean absolute percentage error of 2.12, and the sum of the absolute errors of 78.26.Please note that although there have been many attempts to predict Avalo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Avalo Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Avalo Therapeutics Stock Forecast Pattern
| Backtest Avalo Therapeutics | Avalo Therapeutics Price Prediction | Buy or Sell Advice |
Avalo Therapeutics Forecasted Value
In the context of forecasting Avalo Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Avalo Therapeutics' downside and upside margins for the forecasting period are 12.22 and 21.04, respectively. We have considered Avalo Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Avalo Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Avalo Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.7011 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.2623 |
| MAPE | Mean absolute percentage error | 0.0744 |
| SAE | Sum of the absolute errors | 78.2605 |
Predictive Modules for Avalo Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Avalo Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Avalo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Avalo Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Avalo Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Avalo Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Avalo Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Avalo Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Avalo Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Avalo Therapeutics' historical news coverage. Avalo Therapeutics' after-hype downside and upside margins for the prediction period are 10.67 and 19.49, respectively. We have considered Avalo Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Avalo Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Avalo Therapeutics is based on 3 months time horizon.
Avalo Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Avalo Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Avalo Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Avalo Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 4.41 | 0.03 | 0.03 | 7 Events / Month | 6 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
15.11 | 15.08 | 0.20 |
|
Avalo Therapeutics Hype Timeline
Avalo Therapeutics is presently traded for 15.11. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.03. Avalo is anticipated to decline in value after the next headline, with the price expected to drop to 15.08. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.2%, whereas the daily expected return is presently at -0.07%. The volatility of related hype on Avalo Therapeutics is about 1006.85%, with the expected price after the next announcement by competition of 15.14. About 86.0% of the company shares are held by institutions such as insurance companies. The book value of Avalo Therapeutics was presently reported as 5.14. The company recorded a loss per share of 13.42. Avalo Therapeutics had not issued any dividends in recent years. The entity had 1:240 split on the 29th of December 2023. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Historical Fundamental Analysis of Avalo Therapeutics to cross-verify your projections.Avalo Therapeutics Related Hype Analysis
Having access to credible news sources related to Avalo Therapeutics' direct competition is more important than ever and may enhance your ability to predict Avalo Therapeutics' future price movements. Getting to know how Avalo Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Avalo Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PRLD | Prelude Therapeutics | 3.80 | 26 per month | 11.51 | 0.08 | 16.44 | (16.17) | 206.09 | |
| IVA | Inventiva Sa | 0.1 | 10 per month | 6.86 | 0.03 | 10.82 | (7.47) | 34.91 | |
| EPRX | Eupraxia Pharmaceuticals Common | 0.14 | 7 per month | 2.86 | 0.15 | 6.98 | (4.46) | 24.61 | |
| CRBU | Caribou Biosciences | (0.13) | 7 per month | 0.00 | (0.19) | 6.86 | (6.41) | 20.16 | |
| CHRS | Coherus BioSciences | 0.1 | 22 per month | 4.89 | 0.09 | 10.34 | (7.35) | 19.47 | |
| OBIO | Orchestra BioMed Holdings | 0.37 | 10 per month | 3.88 | (0.01) | 10.17 | (5.98) | 19.34 | |
| AARD | Aardvark Therapeutics Common | 0.18 | 6 per month | 4.46 | 0.07 | 9.25 | (8.66) | 38.70 | |
| TNYA | Tenaya Therapeutics | (0.20) | 5 per month | 0.00 | (0.12) | 10.57 | (11.04) | 51.79 | |
| ENTA | Enanta Pharmaceuticals | 0.22 | 5 per month | 2.61 | 0.1 | 5.67 | (3.59) | 15.79 | |
| BDTX | Black Diamond Therapeutics | (0.20) | 9 per month | 0.00 | (0.12) | 5.96 | (8.35) | 34.11 |
Other Forecasting Options for Avalo Therapeutics
For every potential investor in Avalo, whether a beginner or expert, Avalo Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Avalo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Avalo. Basic forecasting techniques help filter out the noise by identifying Avalo Therapeutics' price trends.Avalo Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avalo Therapeutics stock to make a market-neutral strategy. Peer analysis of Avalo Therapeutics could also be used in its relative valuation, which is a method of valuing Avalo Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Avalo Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Avalo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avalo Therapeutics shares will generate the highest return on investment. By undertsting and applying Avalo Therapeutics stock market strength indicators, traders can identify Avalo Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 29634.82 | |||
| Daily Balance Of Power | (0.19) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 14.99 | |||
| Day Typical Price | 15.03 | |||
| Price Action Indicator | 0.05 | |||
| Period Momentum Indicator | (0.14) | |||
| Relative Strength Index | 43.91 |
Avalo Therapeutics Risk Indicators
The analysis of Avalo Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Avalo Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting avalo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.41 | |||
| Standard Deviation | 4.36 | |||
| Variance | 19.0 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Avalo Therapeutics
The number of cover stories for Avalo Therapeutics depends on current market conditions and Avalo Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Avalo Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Avalo Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Avalo Therapeutics Short Properties
Avalo Therapeutics' future price predictability will typically decrease when Avalo Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Avalo Therapeutics often depends not only on the future outlook of the potential Avalo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Avalo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.8 M | |
| Cash And Short Term Investments | 134.5 M |
Additional Tools for Avalo Stock Analysis
When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.